Your browser doesn't support javascript.
loading
The rivaroxaban-adjusted normalized ratio: use of the prothrombin time to monitor the therapeutic effect of rivaroxaban.
Kim, B; Jang, S; Lee, Y J; Park, N; Cho, Y U; Park, C J.
Affiliation
  • Kim B; a Department of Laboratory Medicine , Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine , Cheonan , Republic of Korea (South Korea).
  • Jang S; b Department of Laboratory Medicine , University of Ulsan College of Medicine and Asan Medical Center , Seoul , Republic of Korea (South Korea).
  • Lee YJ; c Asan Clinical Research Center , Seoul , Republic of Korea (South Korea).
  • Park N; c Asan Clinical Research Center , Seoul , Republic of Korea (South Korea).
  • Cho YU; c Asan Clinical Research Center , Seoul , Republic of Korea (South Korea).
  • Park CJ; b Department of Laboratory Medicine , University of Ulsan College of Medicine and Asan Medical Center , Seoul , Republic of Korea (South Korea).
Br J Biomed Sci ; 76(3): 122-128, 2019 Jul.
Article in En | MEDLINE | ID: mdl-30967043
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prothrombin Time / Thiophenes / Blood Coagulation / International Normalized Ratio / Factor Xa Inhibitors / Rivaroxaban Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Biomed Sci Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prothrombin Time / Thiophenes / Blood Coagulation / International Normalized Ratio / Factor Xa Inhibitors / Rivaroxaban Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Biomed Sci Year: 2019 Document type: Article